I n order to give the best care to patients and families, paediatricians need to integrate the highest quality scientific evidence with clinical expertise and the opinions of the family. 1 Archimedes seeks to assist practising clinicians by providing ''evidence based'' answers to common questions which are not at the forefront of research but are at the core of practice. In doing this, we are adapting a format which has been successfully developed by Kevin Macaway-Jones and the group at the Emergency Medicine Journal-''BestBets''.
A word of warning. The topic summaries are not systematic reviews, through they are as exhaustive as a practising clinician can produce. They make no attempt to statistically aggregate the data, nor search the grey, unpublished literature. What Archimedes offers are practical, best evidence based answers to practical, clinical questions.
The format of Archimedes may be familiar. A description of the clinical setting is followed by a structured clinical question. (These aid in focusing the mind, assisting searching, 2 and gaining answers. 3 ) A brief report of the search used follows-this has been performed in a hierarchical way, to search for the best quality evidence to answer the question. 4 A table provides a summary of the evidence and key points of the critical appraisal. For further information on critical appraisal, and the measures of effect (such as number needed to treat, NNT) books by Sackett 5 and Moyer 6 may help. To pull the information together, a commentary is provided. But to make it all much more accessible, a box provides the clinical bottom lines.
The electronic edition of this journal contains extra information to each of the published Archimedes topics. The papers summarised in tables are linked, by an interactive table, to more detailed appraisals of the studies. Updates to previously published topics will be linked to the original article when they are available.
Electronic-only topics that have been published on the BestBets site (www.bestbets.org) and may be of interest to paediatricians include:
N What dose of dexamethasone should we use in croup? N Is neonatal cranial ultrasound a useful predictor of longterm neurodevelopmental outcome in preterm or low birth weight infants?
N Is monteleukast useful in the treatment of bronchiolitis?
Readers wishing to submit their own questions-with best evidence answers-are encouraged to review those already proposed at www.bestbets.org. If your question still hasn't been answered, feel free to submit your summary according to the Instructions for Authors at www.archdischild.com. Three topics are covered in this issue of the journal. 
Decision analysis
When we make a decision about a course of action-a diagnostic test, treatment, or other intervention-we weigh up more than just a single outcome. There could be beneficial outcomes, but the possibility of negative effects (adverse events, failures, repeat attendance, and so on) also needs to be considered. Diagnostic tests may give the wrong answer, and expose the patient to risks of non-treatment (or of inappropriate treatment). As clinicians, we instinctively assess the chances of the outcomes, weigh them, and conclude on a course of action.
For Decision analysis is a way of modelling all the factors and formally adding up the likely outcomes, and weighting these with values-be these costs, clinician, or patient centred measures of benefit (utilities). (See a previous Archimedes issue, ''Economic analyses'' 1 for more on ''utilities''.) For the clinician the full process can be difficult, time consuming, and monumentally boring. Where the practitioner can use such information is in taking analyses which have already been performed, appraising them, and using them in local practice.
If no analysis exists, it may be worth doing a ''back of the envelope'' analysis. Knowing how good your current treatment is (taking costs and adverse effects into account) will let you know how effective a new treatment has to be to beat it. If you're looking for a bedside diagnostic test, knowing in advance how many false negative and false positives you will accept informs you of the magnitude the likelihood ratios 2 will need to reach. If the target you've set is unfeasible, then the five minutes spent thinking this through may have saved you hours of work. Now, it is stressed that decision analyses are models-not real. Search strategy and outcome Primary source: Medline via Pubmed using keyword ''umbilical artery''. A total of 477 individual articles were found. This was limited to 152 articles by selecting those in English language and human studies relating to neonates (birth-1 month). The search was verified by using (MeSH) subject heading: ''umbilical artery'' + subheading: abnormalities. Individual abstracts were read. A systematic review with meta-analysis of the relevant studies which matched our structured clinical question was found. The meta-analysis and original articles of seven relevant included studies were appraised.
Secondary sources: Cochrane database and Best Bets. No further papers were identified.
See table 1.
Commentary
Single umbilical artery has long been recognised as a soft marker for chromosomal abnormalities and congenital malformations. Autopsy series from aborted and still born fetuses report a high incidence of associated malformations. It is therefore conceivable that if SUA is detected in a neonate with obvious physical abnormalities, full investigatory work up to detect occult malformations of various organ systems has to be undertaken. Nevertheless, in many cases SUA can be an isolated feature. It is unclear if apparently asymptomatic infants with SUA need to be investigated. The meta-analysis cited 1 was a review of 37 studies published over the past 40 years. Eleven of the 37 studies were performed on specimens obtained from autopsy studies of abortusus and stillborn babies. These were not relevant to our question. In the remaining 26 studies, the diagnosis of SUA was made by clinical examination of the placenta or umbilical cord after delivery and thus satisfied our initial criteria. But in only seven of these was there data for asymptomatic isolated SUA. Overall, a mean of 16.2% of infants with isolated SUA had a renal anomaly (median 5.3%). In half these cases (8%) these malformations were severe and persistent on follow up. The most frequent major renal anomaly was vesico-ureteric reflux, grade 2 or greater, in 2.9% of the total population.
In the study by Bourke and colleagues, 2 infants with isolated SUA had a screening ultrasound scan. Those with abnormal scans underwent a micturating cysturethrogram and urine cultures. Vesico-ureteric reflux (VUR) was documented in 4.5% of these infants. It is interesting to note that three of the five infants with VUR developed urinary tract infections (UTI) within the first five months of life.
The incidence of occult renal anomalies in the general paediatric population is about 2.5%; 9 the prevalence of VUR in healthy individuals is unclear. Ransley, 10 in a compilation of several publications, reports a rate of 1.3%.From the currently available evidence it seems that the incidence of silent renal abnormalities in infants with isolated SUA is at least threefold higher for severe malformations and sixfold higher for any renal malformation compared to the general paediatric population. VUR is probably up to three times commoner in these infants. A screening renal ultrasound scan may be useful in detecting occult structural malformations of the urinary tract. However, its positive predictive value in suggesting VUR was low; it was reported as 32.5% in a recent study. 11 As VUR and UTI are believed to be forerunners of reflux nephropathy, it seems prudent to investigate infants born with an isolated SUA by means of a micturating cystourethrogram (MCUG) and maintain a low threshold to diagnose and treat urinary tract infections.
CLINICAL BOTTOM LINE
N There is an increased proportion of significant occult renal malformations in asymptomatic infants born with an isolated single umbilical artery (8% total population).
N A significant proportion of such infants may have vesicoureteric reflux (grade 2 or worse).
N Screening renal ultrasonography and micturating cystourethrography are useful investigations to detect associated renal anomalies in these cases.
N There is a lack of data regarding malformations of other organ systems in infants with asymptomatic isolated SUA. Embase . Search outcome: 111 articles, of which one relevant (already retrieved by Pub Med).
Cinahl 
Commentary
In the two reported studies, 1 2 the indications for transfusion were not standardised, the time interval between transfusion and NEC was not available, and any transfusion at any time between birth and NEC was analysed.
The results of the ecological study 1 are difficult to interpret as the association found between transfusion and NEC was at the level of the NICU but was not studied at the individual neonate level.
Bias in the published results of the two studies is possible, as the findings may be related to other practices in the specific neonatal intensive care unit (e.g. restricted transfusion policy). It may also reflect confounding by the indication for transfusion (e.g, infants who have NEC may require more transfusions). It could also be that the anaemia for which a blood transfusion was requested was an independent risk factor for NEC, or an early manifestation of NEC still developing, which then becomes recognised several hours later (during or after the transfusion).
While anecdotal reports suggest that NEC has developed quickly after a blood transfusion, such information is not available in published studies. However, neonatal exchange transfusion 3 4 and intrauterine transfusion, 5 both via umbilical vessels, have been shown to be associated with an increased incidence of NEC.
Further studies minimising bias and confounding are needed to prove or disprove an association between blood transfusion and the risk of NEC, but even then, association is not necessarily synonymous with causality. It should be possible to undertake randomised controlled studies on the A n asymptomatic 18 month old boy, undergoing radiological investigations after a urinary tract infection (UTI) diagnosed few months earlier, is reviewed at the clinic. According to departmental protocol, a three monthly urine culture should be submitted in infants and young children as, until the age of 4 years, they remain at risk of developing renal scars after UTIs. You wonder as to the value of this routine culture. PubMed : search words-(''urine culture'' OR ''asymptomatic bacteriuria'' OR ''urinary tract infection'') AND (''prognosis'' OR ''renal scar*''). Limits: child ,4 years. Search outcome: 12 papers, of which two were relevant (under 4 years of age).
SumSearch: 43 articles, two relevant (already retrieved by PubMed). See table 3.
As infants and young children are thought to remain at risk, until the age of 4 years, of developing renal scars after UTIs, some paediatric departments carry out periodical urine culture in this group, even in the absence of symptoms. In addition to the fact that urine collection and culture in preschool children under 4 years of age is not always technically easy and is associated with an unsatisfactory high risk of bacterial contamination, detection of ABU in this group would be of value if its treatment results in decreased risk of renal scarring and symptomatic UTI, without adverse effects of the therapy. Previous reports have shown that the development of new renal scars or the progression of existing scars are very uncommon after the age of 4 years, 3 and, although new scars may occasionally develop after the age of 4 years, they generally occur in the context of symptomatic UTI or acute pyelonephritis but not after ABU. 4 Although there is evidence of progression of scarring in relation to ABU, there is no evidence of benefit from treatment. Studies of ABU in schoolchildren have shown that absence of treatment does not increase the risk of subsequent renal scarring after the age of 5 years 5 and that bacterial strains in ABU do not commonly cause symptomatic pyelonephritis. 6 However, changes in bacterial flora have been associated with recurrences of or development of acute pyelonephritis ABU. 7 In children with ABU, the use of antibiotic therapy for intercurrent infections leads to a change in the urinary flora and is associated with an increased risk of pyelonephritis, 8 in contrast to untreated ABU where no spontaneous changes of urinary bacteria occurs. 9 We therefore reviewed all published studies to try answering specifically the structured clinical question: What is the evidence that the detection and management of ABU in preschool children under 4 years of age decrease the incidence of symptomatic UTI or renal scarring? Unfortunately, we found no good quality randomised studies addressing that specific question. The two studies reviewed show that in children under 4 years of age, no new renal scarring occurred when bacteriuria was asymptomatic 1 and that renal scarring only occurred in children with symptomatic recurrences associated with abnormal cystograms. 2 However, both studies have obvious weaknesses: in addition to small sample sizes, there was no treatment randomisation. The first study was carried out in an unselected population of children, but not after a selected group with previous UTI which would very likely have a different natural history and prognosis. The second study was carried out exclusively in girls, who are known to have a different natural history than boys. In addition, as these studies were carried out before DMSA was available, the diagnosis of renal damage was made by intravenous urography (IVU). As DMSA is more sensitive than IVU to detect cortical scarring, some small scars may not have been recognised on IVU, although such small scars are not thought to be clinically significant. In addition, the first study did not clearly differentiate between primary and secondary (after a previous UTI) ABU.
Despite their weaknesses, which should caution about the generalisation of their findings, these studies have shown that the detection and the treatment of ABU in infants and preschool children did not decrease the risk of renal scarring. In addition, N Despite a lack of direct evidence, we continue to withhold feeds during blood transfusion.
antibiotic induced modifications of the bacterial flora may increase the risk of acute pyelonephritis, and therefore the risk of cortical damage. Therefore, the practice of routine detection of bacteriuria in asymptomatic infants and preschool children is not supported by evidence 1 2 and may even be harmful. 7 8 Future randomised double blind controlled studies, clearly differentiating between primary and secondary ABU, with outcomes based on DMSA, are recommended.
